Skip to content

A relative bioavailability study between a fixed dose combination product of Ibuprofen and Paracetamol vs. free combination of Ibuprofen and Paracetamol

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516423-14-00
Acronym
BECRO/BF/BIOFEN
Enrollment
32
Registered
2024-11-20
Start date
2024-12-19
Completion date
2025-02-21
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cold and flu, fever, pain

Interventions

None listed

Sponsors

Biofarm S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Greece

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026